LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,870,972 | – | 2,304,150 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $132,392,000 | 7.07% |
| BVF INC/IL | 14,149,179 | $26,317,000 | 1.27% |
| NEA Management Company, LLC | 2,382,286 | $4,431,000 | 0.23% |
| Parkman Healthcare Partners LLC | 250,000 | $465,000 | 0.17% |
| Integral Health Asset Management, LLC | 300,000 | $558,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 371,598 | $691,000 | 0.10% |
| PINNACLE ASSOCIATES LTD | 2,087,463 | $3,883,000 | 0.08% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $66,000 | 0.03% |
| Pegasus Asset Management, Inc. | 10,000 | $19,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 3,228,072 | $6,004,000 | 0.01% |